Glycans in magnetic resonance imaging: Determinants of relaxivity to smart agents, and potential applications in biomedicine

Current Medicinal Chemistry

Volumn 18, Issue 7, 2011, Pages 1002-1018

  Cipolla, Laura ^a   Gregori, Maria ^a   So, Po Wah ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Carbohydrates; Contrast agents; MRI

Indexed keywords

ARABINOGALACTAN; BETA CYCLODEXTRIN; BIOLOGICAL MARKER; CARBOHYDRATE; CARBOXY DEXTRAN; CARBOXYMETHYLATED DEXTRAN; CONTRAST MEDIUM; CYANOACRYLATE DERIVATIVE; DEXTRAN 40; DEXTRAN DERIVATIVE; DIVINYLBENZENE; GADOFOSVESET; GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIC ACID; GADOTERIDOL; GLYCAN DERIVATIVE; GLYCOSAMINOGLYCAN; MACROGOL; MUCIN 1; NANOPARTICLE; NMS 60; OLIGOSACCHARIDE; POLYALKYLCYANOACRYLATE; POLYCAPROLACTONE; POLYLACTIC ACID; SILOXANE; STYRENE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ARTICLE; BIOCHEMISTRY; BIOMEDICINE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOBIOLOGY; HISTOPATHOLOGY; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR BIOLOGY; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CHEMISTRY; PROTEIN TARGETING; SENSITIVITY AND SPECIFICITY; STRUCTURE ANALYSIS;

ANIMALS; BIOLOGICAL MARKERS; BIOMEDICAL TECHNOLOGY; CONTRAST MEDIA; HUMANS; MAGNETIC RESONANCE IMAGING; POLYSACCHARIDES;

EID: 79952791523     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711794940851     Document Type: Article

References (99)

1. Varki, A.; Cummings, R.; Esko, J.D.; Freeze, H.;. Hart, G.; Marth, J. Essentials in Glycobiology, Cold Spring Harbor Laboratory Press: Plainview, NY, 2002.
2. Feizi, T.; Mulloy, B. Carbohydrates and glycoconjugates. Glycomics: The new era of carbohydrate biology. Curr. Opin. Struc. Biol., 2003, 13, 602-604. (Pubitemid 37244115)
3. Feizi, T. Progress in deciphering the information content of the 'glycome'- a crescendo in the closing years of the millennium. Glycoconjug. J., 2000, 17, 553-565. (Pubitemid 32480344)
4. Ratner, D.M.; Adams, E.W.; Disney, M.D.; Seeberger, P.H. Tools for glycomics: Mapping interactions of carbohydrates in biological systems. ChemBioChem, 2004, 5, 1375-1383. (Pubitemid 39377754)
5. Hollingsworth, R.I.; Wang, G. Toward a carbohydrate-based chemistry: Progress in the development of general-purpose chiral synthons from carbohydrates. Chem. Rev., 2000, 100, 4267-82. (Pubitemid 32090349)
6. Ravi Kumar, M.N.V.; Muzzarelli, R.A.A.; Muzzarelli C.; Sashiwa, H.; Domb, A.J. Chitosan mistry and pharmaceutical perspectives. Chem. Rev., 2004, 104, 6017-84.
7. Morra, M. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules, 2005, 6, 1205-23. (Pubitemid 40775037)
8. Modo, M.M.; Bulte, J.W.W. Molecular and cellular MR imaging, CRC Press: Boca Raton, FL, 2007.
9. Yoo, B.; Pagel, M.D. An overview of responsive MRI contrast agents for molecular imaging. Front. Biosci., 2008, 13, 1733-52. (Pubitemid 351599729)
10. Bottrill, M.; Kwok, L.; Long, N.J. Lanthanides in Magnetic Resonance Imaging. Chem. Soc. Rev., 2006, 35, 557-71. (Pubitemid 43815289)
11. Aime, S.; Geninatti Crich, S.; Gianolio, E.; Giovenzana, G.B.; Teia, L.; Terreno, E. High sensitivity lanthanide(III) based probes for MR-medical imaging. Coord. Chem. Rev., 2006, 250, 1562-79.
12. Strijkers, G.J.; Mulder, W.J.M.; van Tilborg, G.A.F.; Nicolay, K. MRI contrast agents: Current status and future perspectives. Anti-cancer Agent Med. Chem., 2007, 7, 291-305. (Pubitemid 46813466)
13. Lauffer, R.B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: Theory and design. Chem. Rev., 1987, 87, 901-27.
14. Frullano, L.; Meade, T.J. Multimodal MRI contrast agents. J. Biol. Inorg. Chem., 2007, 12, 939-49. (Pubitemid 47353540)
15. Shellock, F.G.; Kanal, E. Safety of magnetic resonance imaging contrast agents. J. Magn. Reson. Imaging, 1999, 10, 477-484. (Pubitemid 29463135)
16. Caravan, P.; Ellison, J.J.; McMurry, T.J.; Lauffer, R.B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications, Chem. Rev., 1999, 99, 2293-2352. (Pubitemid 30498114)
17. Di Marco, M.; Sadun, C.; Port, M.; Guilbert, I.; Couvreur, P.; Dubernet, C. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int. J. Nanomed., 2007, 2, 609-22.
18. Corot, C.; Robert, P.; Idée, J.; Port, M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev., 2006, 58, 1471-1504. (Pubitemid 44820503)
19. McCarthy, J.R.; Weissleder, R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev., 2008, 60, 1241-51.
20. Wang Y.X.; Hussain, S.M.; Krestin, G.P. Superparamagnetic iron oxide contrast agents: Application in MR imaging. Eur. Radiol., 2001, 11, 2319-31.
21. Lin, M.M.; Kim, D.K.; El Haj, A.J.; Dobson, J. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications. IEEE Trans. Nanobiosci., 2008, 7, 298-305.
22. Chouly, C.; Pouliquen, D.; Lucet, I.; Jeune, J.J.; Jallet, P. Development of superparamagnetic nanoparticles for MRI: Effect of particle size, charge and surface nature on biodistribution. J. Microencapsul., 1996, 13, 245-55. (Pubitemid 26149536)
23. Ward, K.M.; Aletras, A.H.; Balaban, R.S. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J. Magn. Reson., 2000, 143, 79-87.
24. Zhou, J.; Wilson, D.A.; Sun, P.Z.; Klaus, J.A.; Van Zijl, P.C. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn. Reson. Med., 2004, 51, 945-52. (Pubitemid 38580606)
25. Terreno, E.; Castelli, D.D.; Cravotto, G.; Milone, L.; Aime S. Ln(III)- DOTAMGly complexes: A versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for Magnetic Resonance Imaging applications. Invest. Radiol., 2004, 39, 235-243. (Pubitemid 38391789)
26. So, P.-W.; Parkes, H.G.; Bell, J.D. Application of magnetic resonance methods to studies of gene therapy, Prog. Nucl. Magn. Reson. Spectrosc., 2007, 51, 49-62. (Pubitemid 46795440)
27. Armitage, F.E.; Richardson, D.E.; Li, K.C.P. Polymeric contrast agents for magnetic resonance imaging: Synthesis and characterization of gadolinium diethylenetriaminepentaacetic acid conjugated to polysaccharides. Bioconjugate Chem., 1990, 1, 365-374.
28. Wang, S.C.; Wikstroem, M.G.; White, D.L.; Klaveness, J.; Holtz, E.; Rongved, P.; Moseley, M.E.; Michael E.; Brash R.C. Evaluation of Gd- DTPA-labeled dextran as an intravascular MR contrast agent: Imaging characteristics in normal rat tissues. Radiology, 1990, 175, 483-88. (Pubitemid 20135289)
29. Bligh, S.W.A.; Harding, C.T.; Sadler, P.J.; Bulman, R.A.; Bydder, G.M.; Pennoock, J.M.; Kelly, J.D.; Latham, I.A.; Marriott, J.A. Use of paramagnetic chelated derivatives of polysaccharides and spin-labeled polysaccharides as contrast agents in magnetic resonance imaging, Magn. Reson. Med., 1991, 17, 516-32.
30. Braybrook, J.H.; Hall, L.D. Carbohydrate contrast agents for nuclear magnetic resonance imaging: Enhancement of the relaxation of water by paramagnetic metal complexes of polysaccharides, Carbohydr. Res., 1989, 187, c6-c8.
31. Rongved, P.; Klaveness, J. Water-soluble polysaccharides as carriers of paramagnetic contrast agents for magnetic resonance imaging: Synthesis and relaxation properties, Carbohydr. Res., 1991, 214, 315-23.
32. Rebizak, R.; Schaefer, M.; Dellacherie, E. Macromolecular contrast agents for magnetic resonance imaging. Influence of polymer content in ligand on the paramagnetic properties. Eur. J. Pharm. Sci., 1999, 7, 243-48 and references cited therein. (Pubitemid 29015742)
33. Mornet, S.; Vasseur, S.; Grasset, F.; Duguet, E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem., 2004, 14, 2161-75.
34. Di Marco, M.; Guilbert, I.; Port, M.; Robic, C.; Couvreur, P.; Dubernet, C. Colloidal stability of ultrasmall superparamagnetic iron oxide (USPIO) particles with different coatings. Inter. J. Pharm., 2007, 331, 197-203. (Pubitemid 46216672)
35. Paul, G.K.; Frigo, T.B.; Groman, J.Y.; Groman, E.V. Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. Bioconjugate Chem., 2004, 15, 394-401. (Pubitemid 38365201)
36. Groman, E.V.; Paul, K.G.; Frigo, T.B. Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohydrate derivatives. 2003, United States Patent 6, 599-498.
37. Mornet, S.; Portier, J.; Duguet, E. A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran. J. Magn. Magn. Mater., 2005, 293, 127-134. (Pubitemid 40608920)
38. Arias, J.L.; Gallardo, V.; Gomez-Lopera, S.A.; Plaza, R.C.; Delgado, A.V. Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. J. Controlled Release, 2001, 77, 309-21. (Pubitemid 33145482)
39. Arias, J.L.; Gallardo, V.; Linares-Molinero, F.; Delgado, A.V. Preparation and characterization of carbonyl iron/poly(butylcyanoacrylate) core/shell nanoparticles. J. Colloid Interface Sci., 2006, 299, 599-607. (Pubitemid 43795782)
40. Bjornerud, A.; Johansson, L.O.; Ahlstrom, H.K. Pre-clinical results with Clariscan (NC100150 Injection); experience from different disease models. MAGMA, 2001, 12, 99-103. (Pubitemid 32510127)
41. Fulton, D.; Elemento, E.M.; Aime, S.; Chaabane, L.; Botta, M.; Parker, D. Glycoconjugates of gadolinium complexes for MRI applications. Chem. Commun., 2006, 1064-1066. (Pubitemid 43344098)
42. Barge, A.; Cravotto, G.; Robaldo, B.; Gianolio, E.; Aime, S. New CD derivatives as self-assembling contrast agents for magnetic resonance imaging (MRI). J. Inclusion Phenom. Macrocycl. Chem., 2007, 57, 489-495.
43. Song, Y.; Kohlmeir, E.K.; Meade, T.J. Synthesis of multimeric MR contrast agents for cellular imaging. J. Am. Chem. Soc., 2008, 130, 6662-63. (Pubitemid 351748375)
44. Aime, S.; Botta, M.; Panero, M.; Grandi, M.; Uggeri, F. Inclusion complexes between β-cyclodextrin and β-benzyloxy-α-propionic derivatives of paramagnetic DOTA- and DPTA-Gd(III) complexes. Magn. Reson. Chem., 1991, 29, 923-27.
45. Battistini, E.; Gianolio, E.; Gref, R.; Couvreur, P.; Fuzerova, S.; Othman, M.; Aime, S.; Badet, B.; Durand, P. High-relaxivity Magnetic Resonance Imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-β-cyclodextrin. Chem. Eur. J., 2008, 14, 4551-61.
46. Maki J.H.; Chenevert T.L.; Prince M.R. Contrast-enhanced MR angiography. Abdom. Imaging, 1998, 23, 469-84. (Pubitemid 28395121)
47. Goyen, M. Gadofosveset-enhanced magnetic resonance angiography. Vasc. Health Risk Manag., 2008, 4, 1-9. (Pubitemid 351460842)
48. de Crespigny, A.J.; Howard, D.; D'Arceuil, H.; Muller, H.; Agoston, A.T.; Seri, S.; Hashiguchi, Y.; Fujimoto, C.; Nakatani, A.; Moseley, M.E. Dynamic contrast-enhanced MRI of Implanted VX2 tumors in rabbit muscle: Comparison of Gd-DTPA and NMS60. Magn. Reson. Imaging, 1999, 17, 1297-305. (Pubitemid 29534103)
49. Tanaka, H.; Ando, Y.; Wada, M.; Takahashi, T. Synthesis of DTPAconjugated (1,4)-linked 2-aminoglycosides varying in the anomeric configuration and their MRI contrast effect. Org. Biomol. Chem., 2005, 3, 3311-28. (Pubitemid 41423967)
50. Yu, G.; Yamashita, M.; Aoshima, K.; Takahashi, M.; Oshikawa, T.; Takayanagi, H.; Laurent, S.; Burtea, C.; Vander Elst, L.; Muller, R.N. A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography? Bioorg. Med. Chem. Lett., 2007, 17, 2246-49. (Pubitemid 46505261)
51. Kamaly, N.; Kalber, T.; Ahmad, A.; Oliver, M.H.; So, P.-W.; Herlihy, A.H.; Bell, J.D.; Jorgensen, M.R.; Miller, A.D. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjug. Chem., 2008, 19, 118-29. (Pubitemid 351213842)
52. So, P.-W.; Hotee, S.; Herlihy, A.H.; Bell, J.D. Generic method for imaging transgene expression. Magn. Reson. Med., 2005, 54, 218-21. (Pubitemid 40898417)
53. Tannous, B.A.; Grimm, J.; Perry, K.F.; Chen, J.W.; Weissleder, R. Metabolic biotinylation of cell surface receptors for in vivo imaging. Nat. Methods, 2006, 3, 391-96.
54. Remsen, L.G.; McCormick, C.I.; Roman-Goldstein, S.; Nilaver, G.; Weissleder, R.; Bogdanov, A.; Hellstrom, K.E.; Kroll, R.A.; Neuwelt, E.A. MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: The potential for noninvasive diagnosis. Am. J. Neuroradiol., 1996, 17, 411-18. (Pubitemid 26101942)
55. Renshaw, P.F.; Owen, C.S.; Evans, A.E.; Leigh, J.S. Jr. Immunospecific NMR contrast agents. Magn. Reson. Imaging,1986, 4, 351-57. (Pubitemid 17172216)
56. Artemov, D.; Mori, N.; Ravi, R.; Bhujwalla, Z.M. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res., 2003, 63, 2723-27. (Pubitemid 36667139)
57. Kang, H.W.; Torres, D.; Wald, L.; Weissleder, R.; Bogdanov, A. Jr. Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer. Lab. Invest., 2006, 86, 599-609. (Pubitemid 43780441)
58. 3-targeted nanoparticles. Magn. Reson. Med., 2000, 44, 433-39.
59. Ohtsubo, K.; Marth, J.D. Glycosylation in cellular mechanisms of health and disease. Cell, 2006, 126, 855-867. (Pubitemid 44310784)
60. Schauer, R. Sialic acid: Fascinating sugar in higher animals and man. Zoology, 2004, 107, 49-64. (Pubitemid 40427891)
61. Miyagi, T.; Wada, T.; Yamaguchi, K.; Hata, K. Sialidase and malignancy: A minireview. Glycoconjugate J., 2004, 20, 189-98. (Pubitemid 39024047)
62. Lemieux, G.A.; Yarema, K.J.; Jacobs, C.L.; Bertozzi, C.R. Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents. J. Am. Chem. Soc., 1999, 121, 4278-79. (Pubitemid 29220304)
63. Lemieux, G.A.; Bertozzi, C.R. Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens. Chem. Biol., 2001, 8, 265-75. (Pubitemid 32296116)
64. Moore, A.; Medarova, Z.; Potthast, A.; Dai, G. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res., 2004, 64, 1821-27. (Pubitemid 38428707)
65. Ho, S.B.; Niehans, G.A.; Lyftogt, C.; Yan, P.S.; Cherwitz, D.L.; Gum, E.T.; Dahiya, R.; Kim, Y.S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res., 1993, 53, 641-51. (Pubitemid 23059449)
66. Barratt-Boyes, S. Making the most of mucin: A novel target for immunotherapy. Cancer Immunol. Immunother., 1996, 43, 142-51. (Pubitemid 26417594)
67. Sivolapenko, G.; Douli, V.; Pectasides, D.; Skarlos, D.; Sirmalis, G.; Hussain, R.; Cook, J.; Courtenay-Luck, N.; Merkouri, E.; Konstantinides, K.; Epenetos, A. Breast cancer imaging with radiolabelled peptide from complementarity- determining region of antitumour antibody. Lancet, 1995, 346, 1662-66. (Pubitemid 26003323)
68. Frullano, L.; Rohovec, J.; Aime, S.; Maschmeyer, T.; Prata, M.I.; Pedroso de Lima, J.J.; Geraldes, C.F.G.C.; Peters, J.A. Towards targeted MRI: New MRI contrast agents for sialic acid detection. Chem. Eur. J., 2004, 10, 5205-17.
69. Laurent, S.; Vander Elst, L.; Fu, Y.; Muller, R.N. Synthesis and physicochemical characterization of Gd-DTPA-B(sLex)A, a new MRI contrast agent targeted to inflammation. Bioconjugate Chem., 2004, 15, 99-103. (Pubitemid 38165985)
70. Fu, Y.; Laurent, S.; Muller, R.N. Synthesis of a sialyl Lewis X mimetic conjugated with DTPA, potential ligand of new contrast agents for medical imaging. Eur. J. Org. Chem., 2002, 23, 3966-73.
71. Barber, P.A.; Foniok, T.; Kirk, D.; Buchan, A.M.; Laurent, S.; Boutry, S.; Muller, R.N.; Hoyte, L.; Tomanek, B.; Tuor, U.I. MR molecular imaging of early endothelial activation in focal ischemia. Ann. Neurol., 2004, 56, 116-20. (Pubitemid 38857366)
72. Sibson, N.R.; Blamire, A.M; Bernades-Silva, M.; Laurent, S.; Boutry, S.; Muller, R.N.; Styles, P.; Anthony, D.C. MRI detection of early endothelial activation in CNS inflammation. Magn. Reson. Med., 2004, 51, 248-52. (Pubitemid 38168583)
73. Boutry, S.; Laurent, S.; Vander Elst, L.; Muller, R.N. Specific E-selectin targeting with a superparamagnetic MRI contrast agent. Contrast Med. Mol. Imaging, 2006, 1, 15-22.
74. Kang, H.W.; Josephson, L.; Petrovsky, A.; Weissleder, R.; Bogdanov, A.J. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. Bioconj. Chem., 2002, 13, 122-27. (Pubitemid 34119643)
75. Lundquist, J.J.; Toone, E.J. The cluster glycoside effect. Chem. Rev., 2002, 102, 555-78. (Pubitemid 35377623)
76. Cavagna, F.; Daprà, M.; Maggioni, F.; De Haën, C.; Felder, E. Gd- BOPTA/dimeg: Experimental disease imaging. Magn. Reson. Med., 1991, 22, 329-33.
77. Willich, H.S.; Brehm, M.; Ewers, C.L.J.; Michl, G.; Fahrnow, A.M.; Petrov, O.; Platzek, J.; Raduchel, B; Sülzle, D. Synthesis and physicochemical characterization of a new gadolinium chelate: The liver-specific Magnetic Resonance Imaging contrast agent Gd-EOB-DTPA. Inorg. Chem., 1999, 38, 1134-44.
78. Rocklage, S.M.; Cacheris, W.P.; Quay, S.C.; Hahn, F.E.; Raymond, K.N. Manganese(II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'- bis(phosphate). Synthesis and characterization of a paramagnetic chelate for magnetic resonance imaging enhancement. Inorg. Chem., 1989, 28, 477-485.
79. Papisov, M.I.; Bogdanov, A.; Schaffer, B.; Nossif, N.; Shen, T.; Weissleder, R.; Brady, T.J. Colloidal magnetic resonance contrast agents: Effect of particle surface on biodistribution. J. Magn. Magn. Mater., 1993, 122, 383-86.
80. Kabalka, G.W.; Davis, M.A.; Moss, T.H.; Buonocore, E.; Hubner, K.; Holmberg, E.; Maruyama, K.; Huang, L. Gadolinium-labeled liposomes containing various amphiphilic Gd-DTPA derivatives: Targeted MRI contrast enhancement agents for the liver. Magn. Res. Med., 1991, 19, 406-15.
81. André, J.P.; Tòth, F.; Fischer, H.; Seelig, A.; Mäcke, H.R.; Merbach, A.E. High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents, thanks to micellar selforganization. Chem. Eur. J., 1999, 5, 2977-83. (Pubitemid 129611675)
82. Weissleder, R.; Reimer, P.; Lee, A.S.; Wittenberg, J.; Brady T.J. Ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. Am. J. Roentgenol., 1990, 155, 1161-67.
83. Reimer, P.; Weissleder, R.; Lee, A.S.; Wittenberg, J.; Brady, T.J. Receptor imaging: Application to MR imaging of liver cancer. Radiology, 1990, 177, 729-34.
84. Reimer, P.; Weissleder, R; Brady, T.J.; Yeager, A.E.; Baldwin, B.H.; Tennant, B.C; Wittenberg, J. Experimental hepatocellular carcinoma: MR receptor imaging. Radiology, 1991, 180, 641-45.
85. Vera, D.R.; Buonocore, M.H.; Wisner, E.R.; Katzberg, R.W.; Stadalnik, R.C. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver. Acad. Radiol., 1995, 2, 497-506.
86. Gallez, B.; Lacour, V.; Demeure, R.; Debuyst, R.; Dejehet, F.; Dekeyser, J.L.; Dumont, P. Spin labelled arabinogalactan as MRI contrast agent. Magn. Reson. Imaging, 1994, 12, 61-69.
87. Fulton, D.A.; Elemento, E.M.; Aime, S.; Chaabane, L.; Botta, M.; Parker, D. Glycoconjugates of gadolinium complexes for MRI applications. Chem. Commun., 2006, 10,1064-66. (Pubitemid 43344098)
88. Baía, P.; André, J.P.; Geraldes, C.F.G.C.; Martins, J.A.; Merbach, A.E.; and Tóth, É. Lanthanide(III) chelates of DTPA bis(amide) glycoconjugates: Potential imaging agents targeted at the asyaloglycoprotein receptor. Eur. J. Inorg. Chem., 2005, 11, 2110-19. (Pubitemid 40831278)
89. André, J.P.; Geraldes, C.F.G.C.; Martins, J.A.; Merbach, A.E.; Prata, M.I.M.; Santos, A.C.; Lima, J.J.P.; Tóth, É. Lanthanide(III) complexes of DOTA- glycoconjugates: A potential new class of lectin-mediated medical imaging agents. Chem. Eur. J., 2004, 10, 5804-16.
90. Prata, M.I.M.; Santos, A.C.; Torres, S.; André, J.P.; Martins, J.A.; Neves, M.; Garcìa-Martìn, M.L.; Rodrigues, T.B.; Lòpez-Larrubia, P.; Cerdàn, S.; Geraldes, C.F.G.C. Targeting of lanthanide(III) chelates of DOTA-type glycoconjugates to the hepatic asyaloglycoprotein receptor: Cell internalization and animal imaging studies. Contrast Med. Mol. Imaging, 2006, 1, 246-58.
91. Takahashi, M.; Hara, Y.; Aoshima, K.; Kurihara, H.; Oshikawa, T.; Yamashita, M. Utilization of dendritic framework as a multivalent ligand: A functionalized gadolinium(III) carrier with glycoside cluster periphery. Tetrahedron Lett., 2000, 41, 8485-88.
92. Louie, A.Y.; Hüber, M.M.; Ahrens, E.T.; Rothbächer, U.; Moats, R.; Jacobs, R.E.; Fraser, S.E.; Meade, T.J. In vivo visualization of gene expression using magnetic resonance imaging. Nature Biotechnology, 2000, 18, 321-25. (Pubitemid 30159486)
93. Wardle, N.J.; Herlihy, A.H.; So, P.-W.; Bell, J.D.; Bligh, S.W.A. Synthesis of a novel 'smart' bifunctional chelating agent 1-(2-[β, dgalactopyranosyloxy] ethyl)-7-(1-carboxy-3-[4-aminophenyl]propyl)-4,10- bis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (Gal-PA-DO3A-NH2) and its Gd(III) complex. Bioorg. Med. Chem., 2007, 15, 4714-21. (Pubitemid 46836843)
94. Josephson, L.; Tung, C.H.; Moore, A.; Weissleder, R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjugate Chem., 1999, 10, 186-91. (Pubitemid 29147720)
95. Cui, W.; Otten, P.; Li, Y.; Koeneman, K.S.; Yu, J.; Mason, R.P. Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl- dgalactopyranoside as a prototype reporter molecule for β-galactosidase. Magn. Reson. Med., 2004, 51, 616-20. (Pubitemid 38298678)
96. Kodibagkar, V.D.; Yu, J.; Liu, L.; Hetherington, H.P.; Mason, R.P. Imaging beta-galactosidase activity using 19F chemical shift imaging of LacZ genereporter molecule 2-fluoro-4-nitrophenol-beta-d-galactopyranoside. Magn. Reson. Imaging, 2006, 24, 959-62. (Pubitemid 44205386)
97. Duimstra, J.A.; Femia, F.J.; Meade, T.J. A gadolinium chelate for detection of β-glucuronidase: A self-immolative approach. J. Am. Chem. Soc., 2005, 127, 12847.
98. Amir, R.J.; Pessah, N.; Shamis, M.; Shabat, D. Self-immolative dendrimers. Angew. Chem. Int. Ed., 2003, 42, 4494-99. (Pubitemid 37214522)
99. Chauvin, T.; Durand, P.; Bernier, M.; Meudal, H.; Doan, B.T.; Noury, F.; Badet, B.; Beloeil, J.-C.; Tóth, É. Detection of enzymatic activity by PARACEST MRI : A general approach to target a large variety of enzymes. Angew. Chem. Int. Ed., 2008, 47, 4370-72.